InvestorsHub Logo

monte379

03/13/20 9:59 AM

#99467 RE: rrao11 #99466

What will be interesting rrao11 is when we know more about StemSpine too. How many offices and kits have they used???

It may be quarter or two away from decent revs, but the self sufficiency they anticipated last year could come this year IMO.

Hindsight tells us that adding the 100 2.0 patients to the study was a smart move for the company, but costly to the shareholders as it delayed the paper a year.

And as some have pointed out, the pre RS equivalent is this PPS is truly at four zero trading. You can hardly buy in any lower. (I know, I know....it’s going to trips again and another RS LOL).

Even though my fans like to say I am an insider (ROTFLMAO) none of us knew about these last few doctors or even the info on IMMCELZ. That makes me wonder what else CMTH is holding close to the chest?

Interesting times none the less.

uplinkjim

03/13/20 10:05 AM

#99468 RE: rrao11 #99466

Great Another Day and another Office. money money money